In the study, Hepa 1-6: A murine model of hepatocellular carcinoma, Labcorp researcher, Sumithra Urs, studied an HCC tumor model’s response to radiation with SARRP. See more below and the full article here.
Xstrahl Announces Landmark Education Program for SARRP Users to Advance Preclinical Radiation Research
Xstrahl, a global leader in the delivery of superficial radiation therapy devices and preclinical radiation research systems, will demonstrate Xstrahl 200, a modern orthovoltage radiotherapy solution for treating superficial lesions, skin cancers, and selective benign conditions. Visit Xstrahl at booth 220 at the ACRO Summit 2025 – The Radiation Oncology Summit located at Planet Hollywood, Las Vegas, NV from March 12-15, 2025.
